INDRAMEDCOHospital
Indraprastha Medical Corporation Ltd — Profit & Loss Statement
₹372.35
-4.91%
Indraprastha Medical Corporation Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -0.23 Cr | -1.49 Cr | — |
| Tax Rate For Calcs | 0.26 | 0.25 | 0.26 | 0.26 | — |
| Normalized EBITDA | 266.92 Cr | 210.25 Cr | 157.78 Cr | 120.39 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | -0.87 Cr | -5.77 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | -0.87 Cr | -5.77 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 160.99 Cr | 123.96 Cr | 86.15 Cr | 58.62 Cr | — |
| Reconciled Depreciation | 44.33 Cr | 40.08 Cr | 39.27 Cr | 34.94 Cr | — |
| Reconciled Cost Of Revenue | 862.74 Cr | 790.59 Cr | 720.30 Cr | 597.16 Cr | — |
| EBITDA | 266.92 Cr | 210.25 Cr | 156.91 Cr | 114.62 Cr | — |
| EBIT | 222.59 Cr | 170.17 Cr | 117.64 Cr | 79.68 Cr | — |
| Net Interest Income | -6.27 Cr | -4.06 Cr | 5.75 Cr | -0.29 Cr | — |
| Interest Expense | 6.27 Cr | 4.06 Cr | 0.46 Cr | 0.61 Cr | — |
| Normalized Income | 160.99 Cr | 123.96 Cr | 86.79 Cr | 62.90 Cr | — |
| Net Income From Continuing And Discontinued Operation | 160.99 Cr | 123.96 Cr | 86.15 Cr | 58.62 Cr | — |
| Total Expenses | 1.16K Cr | 1.09K Cr | 952.65 Cr | 777.01 Cr | — |
| Diluted Average Shares | 9.17 Cr | 9.17 Cr | 9.17 Cr | 9.17 Cr | — |
| Basic Average Shares | 9.17 Cr | 9.17 Cr | 9.17 Cr | 9.17 Cr | — |
| Diluted EPS | 17.56 | 13.52 | 9.40 | 6.39 | — |
| Basic EPS | 17.56 | 13.52 | 9.40 | 6.39 | — |
| Diluted NI Availto Com Stockholders | 160.99 Cr | 123.96 Cr | 86.15 Cr | 58.62 Cr | — |
| Net Income Common Stockholders | 160.99 Cr | 123.96 Cr | 86.15 Cr | 58.62 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 160.99 Cr | 123.96 Cr | 86.15 Cr | 58.62 Cr | — |
| Net Income Including Noncontrolling Interests | 160.99 Cr | 123.96 Cr | 86.15 Cr | 58.62 Cr | — |
| Net Income Continuous Operations | 160.99 Cr | 123.96 Cr | 86.15 Cr | 58.62 Cr | — |
| Tax Provision | 55.33 Cr | 42.15 Cr | 31.03 Cr | 20.45 Cr | — |
| Pretax Income | 216.32 Cr | 166.11 Cr | 117.18 Cr | 79.07 Cr | — |
| Other Non Operating Income Expenses | 22.65 Cr | 16.89 Cr | 10.03 Cr | 3.12 Cr | — |
| Special Income Charges | 0.00 | 0.00 | -0.87 Cr | -5.77 Cr | — |
| Net Non Operating Interest Income Expense | -6.27 Cr | -4.06 Cr | 5.75 Cr | -0.29 Cr | — |
| Interest Expense Non Operating | 6.27 Cr | 4.06 Cr | 0.46 Cr | 0.61 Cr | — |
| Operating Income | 199.94 Cr | 153.28 Cr | 112.30 Cr | 85.13 Cr | — |
| Operating Expense | 293.68 Cr | 300.83 Cr | 232.35 Cr | 179.85 Cr | — |
| Other Operating Expenses | 249.35 Cr | 260.75 Cr | 125.29 Cr | 107.18 Cr | — |
| Depreciation And Amortization In Income Statement | 44.33 Cr | 40.08 Cr | 39.27 Cr | 34.94 Cr | — |
| Depreciation Income Statement | 44.33 Cr | 40.08 Cr | 37.84 Cr | 34.94 Cr | — |
| Gross Profit | 493.62 Cr | 454.11 Cr | 344.65 Cr | 264.98 Cr | — |
| Cost Of Revenue | 862.74 Cr | 790.59 Cr | 720.30 Cr | 597.16 Cr | — |
| Total Revenue | 1.36K Cr | 1.24K Cr | 1.06K Cr | 862.14 Cr | — |
| Operating Revenue | 1.36K Cr | 1.24K Cr | 1.06K Cr | 862.14 Cr | — |
| Interest Income | — | 16.89 Cr | 10.03 Cr | 3.12 Cr | 0.68 Cr |
| Rent Expense Supplemental | — | 2.35 Cr | 2.19 Cr | 1.86 Cr | 2.01 Cr |
| Other Special Charges | — | 1.17 Cr | 0.87 Cr | 5.77 Cr | 0.71 Cr |
| Total Other Finance Cost | — | 3.00 Cr | 3.82 Cr | 2.80 Cr | 3.34 Cr |
| Interest Income Non Operating | — | 16.89 Cr | 10.03 Cr | 3.12 Cr | 0.68 Cr |
| Amortization | — | 0.62 Cr | 1.43 Cr | — | — |
| Selling General And Administration | — | 115.97 Cr | 96.96 Cr | 60.21 Cr | 32.09 Cr |
| Selling And Marketing Expense | — | 104.22 Cr | 87.27 Cr | 53.35 Cr | 26.44 Cr |
| General And Administrative Expense | — | 11.75 Cr | 9.69 Cr | 6.86 Cr | 5.65 Cr |
| Rent And Landing Fees | — | 2.35 Cr | 2.19 Cr | 1.86 Cr | 2.01 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Indraprastha Medical Corporation Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.